Prophylactic use of cardiac medications for delay of left ventricular dysfunction in Duchenne muscular dystrophy.

Proactive cardiac treatment and monitoring are critical aspects of managing Duchenne muscular dystrophy. Consistent with clinical care guidelines, this study supports clinical benefit from cardiac medications initiated prior to documented LVD and suggests further benefit when combined with corticosteroids.